| HOME >> MEDICINE >> TECHNOLOGY |
Financial Table Follows:Consolidated Statements of OperationsIn Thousands, Except per Share Amounts(unaudited)Three Months Ended
June 30,Six Months Ended
June 30,2010201120102011Revenue, net:Core companion animal health
$
13,731$
14,023$
29,523$
30,464Other vaccines, pharmaceuticals and products1,3763,4243,2786,488Total revenue, net 15,10717,44732,80136,952Cost of revenue9,2609,97820,74921,185Gross profit5,8477,46912,05215,767Operating expenses:Selling and marketing3,6563,5707,6927,530Research and development3887038451,034General and administrative2,0102,3094,2104,776Total operating expenses6,0546,58212,74713,340Operating income (loss)(207)887(695)2,427Interest and other expense, net122142295165Income (loss) before income taxes(329)745(990)2,262Income tax expense (benefit):Current tax expense145364159Deferred tax expense (benefit)(178)235(559)730Total income tax expense (benefit)(164)288(495)889Net income (loss)
$
(165)$
457$
(495)$
1,373Basic net income (loss) per share
$
(0.03)$
0.09$
(0.09)$
0.26Diluted net income (loss) per share
$
(0.03)$
0.09$
(0.09)$
0.26Shares used for basic net income (loss) per share5,2175,2345,2165,233Shares used for diluted net income (loss) per share5,2175,3535,2165,298Balance Sheet DataIn Thousands (unaudited)December 31,
'/>"/>
| SOURCE Heska Corporation Copyright©2010 PR Newswire. All rights reserved |